A Preview Of Biolase's Earnings
Portfolio Pulse from Benzinga Insights
Biolase (NASDAQ:BIOL) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-1.85. The company's stock price has historically been affected by its earnings performance and guidance. Last quarter, Biolase beat EPS by $1.09, resulting in a 13.87% drop in share price the next day. The company's shares are currently trading at $1.58 and have dropped 99.01% over the last 52-week period.
November 08, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biolase's upcoming earnings report could potentially impact its stock price. The company's past earnings performance and guidance have historically affected its share price. Given the negative returns over the past year, long-term shareholders may be bearish going into this earnings release.
Biolase's stock price has historically been affected by its earnings performance and guidance. Last quarter, the company beat its EPS estimate, which led to a significant drop in its share price. Given the negative returns over the past year, long-term shareholders may be bearish going into this earnings release. Therefore, the upcoming earnings report could potentially have a negative impact on Biolase's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100